Interestingly, shortly after a specific PPM1D inhibitor became available28, a number of studies demonstrated synergistic effects of dual MDM2 and PPM1D inhibition resulting in an augmented apoptotic response in cancer cell lines both in vitro and in xenograft models29–33. The gene discussed is MDM2; the disease is cancer.